leftspacer middlespacer rightspacer
Media Menu
Featured Material


MAPS BULLETIN
MAPS Bulletin Summer 2014: Research Edition
 
Media > Ibogaine
November 9, 2012

New Zealand Ibogaine Study Enrolls Fifth Subject

On November 9, 2012, the fifth participant was enrolled in our ongoing observational study of ibogaine treatment for addiction in New Zealand. All participants had been receiving methadone treatment for opiate addiction and are being treated for methadone dependence at independent ibogaine clinics in New Zealand. The study was approved by the IRB on February 22, 2012, and lead investigator Dr. Geoff Noller, Ph.D., began enrollment shortly thereafter. This study is the second in our international series of observational studies of the safety and long-term effectiveness of ibogaine treatment for addiction, building on our completed study in Mexico.



Back to Ibogaine Research

Give Our Veterans Hope
1 in 7 Iraq and Afghanistan veterans suffer from PTSD, in many cases leading to suicide. We owe it to our veterans to stop this epidemic.

Tell the Pentagon to fund MAPS' groundbreaking work to treat PTSD.